Science Archives - Crohn's MAP Vaccine

A phase 1b clinical trial to determine the safety, tolerability and immunogenicity of simian adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies in patients with active Crohn’s disease

A message from Amy. I’m delighted to share...

IBD research at Lancaster University

Could you help MAP research by taking part in...

Q & A with vaccinologist Dr Tom Merritt on viral vector vaccines – including the current Covid vaccine from Astra Zeneca.

What follows is a transcript of the Q&A...

Anti-Mycobacterial Antibiotic Therapy Induces Remission in Active Paediatric Crohn’s Disease

This is the latest paper from Dr Agrawal and...

Targeted Combination Antibiotic Therapy Induces Remission in Treatment-Naïve Crohn’s Disease: A Case Series

In this recent paper from Professor Thomas...

Tom’s Trial Blog – June 2017

Howdy All- So it’s come to my attention that...

The "Cursed Village"

We recently received this PDF. About...

Review of Latest Research on Possible Link Between Mycobacterium avium subsp. paratuberculosis (MAP) and Crohn’s Disease

We are pleased to announce that the Review...